Novo Nordisk A/SNVONYSE
Loading
ROE: Returns DecliningContracting
Percentile Rank14
3Y CAGR-7.4%
5Y CAGR-4.5%
Year-over-Year Change
Return on equity
3Y CAGR
-7.4%/yr
vs -2.8%/yr prior
5Y CAGR
-4.5%/yr
Consistent
Acceleration
-4.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 52.79% | -25.0% |
| 2024 | 70.38% | -10.4% |
| 2023 | 78.53% | +18.1% |
| 2022 | 66.51% | -1.5% |
| 2021 | 67.50% | +1.4% |
| 2020 | 66.54% | -1.6% |
| 2019 | 67.63% | -9.2% |
| 2018 | 74.52% | -2.6% |
| 2017 | 76.54% | -8.6% |
| 2016 | 83.78% | - |